NCT05706090 is a NA clinical trial of fentanyl will be added in PATIENTS WITH UPPER EXTREMITY SURGERY, sponsored by Gaziosmanpasa Research and Education Hospital.

Who is sponsoring NCT05706090?

NCT05706090 is sponsored by Gaziosmanpasa Research and Education Hospital.

What drugs are being tested in NCT05706090?

Interventions in NCT05706090: fentanyl will be added, general anesthesia.

What condition does NCT05706090 study?

NCT05706090 studies PATIENTS WITH UPPER EXTREMITY SURGERY.

Is NCT05706090 still recruiting?

NCT05706090 is currently completed. Last updated 31 January 2023.

Last reviewed 2023-01-31 · How we verify

NCT05706090

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Neurostimulator Usage on Block Success

Completed NA Last updated 31 January 2023

What this trial tests

NA trial testing fentanyl will be added in PATIENTS WITH UPPER EXTREMITY SURGERY in 60 participants. Completed in 2 January 2021.

Timeline

1 February 2020

Primary endpoint
1 February 2020

2 January 2021

Quick facts

Lead sponsor	Gaziosmanpasa Research and Education Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	60
Start date	1 February 2020
Primary completion	1 February 2020
Estimated completion	2 January 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

fentanyl will be added — full drug profile →
general anesthesia — full drug profile →

Conditions studied

PATIENTS WITH UPPER EXTREMITY SURGERY — all drugs for PATIENTS WITH UPPER EXTREMITY SURGERY →

Sponsor

Gaziosmanpasa Research and Education Hospital

Who can join

Adults 18 to 80, any sex, with PATIENTS WITH UPPER EXTREMITY SURGERY. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The need of a neurostimulator for a successful nerve block was questioned in different block types after ultrasound has become standard. The aim of this clinical study was to determine the effect of neurostimulator use on block success in costoclavicular block

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Gaziosmanpasa Research and Education Hospital trials

Trials by the same sponsor.

NCT07459400 — The Effect of Peloidotherapy in Young Adults Undergoing Physical Therapy Scoliosis Specific Exercises (PSSE) · not yet recruiting
NCT07366814 — Pipelle Versus Karman Endometrial Biopsy Under Standardized Paracervical Block · NA · completed
NCT07372430 — Proximal Versus Distal Superior Cluneal Nerve Block in Entrapment Neuropathy · recruiting
NCT07459413 — Oral vs. Intravenous Hydration to Prevent Contrast-Associated Acute Kidney Injury in the ED · NA · recruiting
NCT07272213 — Thyroid-Stimulating Hormone Levels in Pregnancy and Their Association With Depression, Anxiety, and Sexual Function · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05706090 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gaziosmanpasa Research and Education Hospital
Last refreshed: 31 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05706090.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing